Strategic partnerships Bayer engages in multi-regional expansion and collaboration, evidenced by ADIO partnership and investments in Africa and the Americas, signaling opportunities for life sciences, agritech, and regional manufacturing/innovation initiatives.

Manufacturing expansion Significant facility expansions in Mexico and investment in seed processing in Zambia indicate Bayer's ongoing capacity buildout, creating potential for supply chain, logistics, and equipment modernization opportunities.

Product portfolio Diversified focus across prescription women's health, cardiology, oncology, hematology, ophthalmology, and radiology imaging, suggesting cross-sell potential into related therapeutic areas and radiology contrast agents.

Sustainability & biofuels Introduction of a biofuels platform featuring camelina, winter canola, and CoverCress points to opportunities in sustainable agriculture tech, specialty crops, and related biotech or processing solutions.

Risk & compliance Recent litigation and recalls related to birth control products underscore the importance of quality assurance, regulatory advisory, and risk mitigation services that can support Bayer across markets.